Research Analysts Set Expectations for PVLA FY2026 Earnings
Palvella Therapeutics (NASDAQ:PVLA – Free Report) – Stock analysts at Cantor Fitzgerald issued their FY2026 earnings per share estimates for Palvella Therapeutics in a research note issued on Monday, June 9th. Cantor Fitzgerald analyst J. Schimmer expects that the company will post earnings of ($2.73) per share for the year. The consensus estimate for Palvella […]
